pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-190b |
Genomic Coordinates | chr1: 154193665 - 154193743 |
Description | Homo sapiens miR-190b stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | |
---|---|
Mature miRNA | hsa-miR-190b |
Sequence | 11| UGAUAUGUUUGAUAUUGGGUU |31 |
Evidence | Not_experimental |
Experiments | |
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | KIAA0232 | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | KIAA0232 | ||||||||||||||||||||
Transcript | NM_001100590 | ||||||||||||||||||||
Other Transcripts | NM_014743 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on KIAA0232 | |||||||||||||||||||||
3'UTR of KIAA0232 (miRNA target sites are highlighted) |
>KIAA0232|NM_001100590|3'UTR 1 ACCTGCAAAATAGTACAAATTATTGTTTAAAAATGATATGTGATGGAAAATTACTCTTCAGTGAGACCTGTTAATCTAAA 81 ACAACAACTTAGGTTTCCTCTTCAATTAACTGATTCAGATTGGTAATAATTATCTTTCTCTTCTTGCTTATTTTAGAGTT 161 GAGGACAGCTATCCTGTTAAAGATTTTTTTTCCCAGCTGTTAAATTCTTGGCTATTTGAAATAGACTAGATTGTGTTGTC 241 AAATCAAGAATGGGTGTGCATGTGCTTGTCTTAGAAGTATCACTGCTTTTTGCATCTTAACTGCAGTTAATTTTCCTTCC 321 GACTGCGGTTATATCACTATGACCTTACTAGCATTGCAGTGTCAACAACCACTTCTGCTCTTCAGAGACTTCAGCTTTGG 401 AGCATTTAGGCTTTGTTCTCCAAGAACTGGGATATCCATTCTTACCCTACAGTGGCTTGATGCCTTTCTGAAGGCGAGAG 481 GGAAGCCTGGGTGACTCAGCGGTGGTCTCCATTCAGCAAAATCTCATGTACATTTCCAGTAGGAACCGCAGAGGTGTGCT 561 TTTCAAGACTCACCAAATACTGTGTTTTCTCTCTTAGGATTTCTTTTCCCCTAAAGTATCACGGAAGATACTATGGTTCG 641 TGACTTTCTTGCTAACTGAAGAAGCCAAGGATTTGGGGTGTGGGGTCGTATGCGAGACACAGTGGGGTAAGGGTGCATAC 721 CCCACCCCTTACCTGCTCTCATACTGCAGTTACATTTACACCAAAACCCCATGCAGGGTTCTTTGTGGTGAGTGTTCCAT 801 ACGTGCTAAGGACCTTAGTTACAGATTGTTACTTTCTGGTGACCTATGTTGAATTGAAACCCCCAAAACTTGAAATTGTG 881 AACATTTGACATGCAGTAAAGGCCACCTCATCACCCAGAGAAATCTTTGGCTGCTGCAGCTAGCCGCTTCTTGGCTGTGA 961 TGTAGTATAGCTTCGATCTCATTTTGTGTTTGAGAGAATGTTCTGGGCAAGTTCTGTGTGTGGTGGGTTGGGGCGGGTAG 1041 AGTCATGAGTTTTCCACATCCCTGTGTGGTGGTTTTGCTGACTGTCGCTCCGTGGGACTGGCTCCCGTTTCTCCTTGGTG 1121 AGCCCGGGGAGCCGGCGCATCTTGTGAGTCGCGTCTGTGCATGGCGATCCGCTCCTCCGGCTCTCATGGCATTGTGCCAC 1201 AGGCAGAGGCCAGGAGGAGCAGTATGTGCACAGCCGAAACATTTTACATTTTTTACATTGTTTTTCTTTTTTAACCAACT 1281 CATTGTTTAAAAAACAAAAACAAAAAAAACCTAATCTGTGAAATCAGCGTAGCATGCCTGGAGCATCAGGAATGGCAGAA 1361 AAGTCTGATGCGCTCTAGACAGCTTCACCACTCATTTGGGCAGGCAGTAAACACACATATAATTTATTAGCTGGGAGCTG 1441 AACTGGCTGTGAAATCTATGATTTGCTTTGAACATTTGGGTTTTGTTGCCTTTTTCTTAATTGATAACACAGAAAAGAAA 1521 GTACCATCAAAGACTGTGGAGTCATTGAGGGTCTGTGTGTCCTCACCGAGAGGGACCTGGTGTGCCCGCCGGGTCGATCT 1601 TCCCACGTGTTAGGGTTTATTTTTATACAACACATCTTTTGACACTTTAAGGTGGGTGGGTGTGTGTGTGTGTGTGTGTG 1681 TGCGCGCGTGCGCGCGCGCATGTGTAAGGTTTTATGTTGCTGTTATTTATTTACGAACTTCAGATACGTTTTTATGTATT 1761 TTTCATTCTTCTGGAGCTTCCTAAAAATTGATAAGCATCTGCACTGAAATATAATTTAACAGCAAAAGTAAAAAAGGATT 1841 GAAAGTTGTAAATTCCTCATATCACTACAGTGACGATTATTCTAGAAATCGTTGCTTGTGTAGCAAAGACCAAATAAATA 1921 GATTTCAGACACAACCTTGAGCACAGTTGATTTTGGACAGCTGCTGTTTATTAGGAAAGGGCTCCAGGTGGCAAAGGTGC 2001 ACACTTCCTCAGACACAGGTGAGAAGATGCAGCACCTTCCACAGGTGAATGGGACGGATTCGAAGTGAGCAAAGGGATTC 2081 ACAAATTATGTATTTATTTGTTTTCATAGTTAAGTAGCTGAAGCTCAGAGGCTTTCAGCAACAGAGATGAAAGTGTGGCT 2161 TTTTAGTTTTGTGAATGGATGATCACAAAGAAAAAGCATTTTTAAAAAGTTGGCAAACGCTGAAACGCACTGTGGTATGA 2241 AGCGCATTGCATTTCCATAGCACTGAAGTACCAGTTTCCATTCCTGGGCTGAGATTGTTTTTCCCGTGGTTGTATTGTTC 2321 TGATTTCACGTACACCAGAGTAACTGATTTTTTTTTGTTTGTTTTCTTGTGGAGTTAACACCAAATAAAAATTGTAAAAA 2401 ACAGTTTGTTGTTTTTATTTCTCATAGCAAAGCTTCTTTTGTAAAGAACTCCAGCTTCCTTTTACTCATGAGCATCCGTG 2481 GAAGAGCAAGTGCCCAGGTTACATTTGTTCTAGATGGAGGTCATTTAGCTCTCATTGCAGACACTGCTGAAAACATTGTG 2561 CAGCTTTGCTAGGGAAGAAAGTGGTGTGGCCTGCTGAGAAATCAGCGGCTCCTCCCCATCTCACCCCCAGCACACGCAGG 2641 GACTACTACCTGAGTCTGCAAAACACATAGCATTTTTGTCCGTGGATGGTACACAAAGCTCAATCTTTTTGTTTTCTTCT 2721 GGGGAAAAAATTAAATCTTTATATGTTAATATGATTGATATTCATTGTGCAAAAAAAATCAGTGTGTTTTTAAAGAAGTA 2801 TAAGGGAAAAGGAAAACTCATATGTCCTTCTGTCACTCTGAGACATACACTGGTAACATCTGTGCAAGCCCCTTTCCAGG 2881 ATTCTGAATGTACAGTATATATGAATGCATACACAGAGAAATTTACATTCAAGAGTGTACTATACTTGTTCTTCTATAAC 2961 ATCAGAAATAGGTTTTTACTCAGATGTCTTCATGTCGGTAATTATAGAACTACATAATTATTTTTATAGCTGTATTATGT 3041 AGATTTAACAGGTTCCTCATTGATAAAACAATGTTTTTTTGGTTGTTTATTCAGTATCTGAATAACGTTTCTATGGACAT 3121 CTGTAAACATGTATGAGGGGACTTTTAAAAGTTCATGGAAAATGGAATTAAAAGAAAAATAAAAAAATATAAACTTTATT 3201 TCTCAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545213. RNA binding protein: AGO2. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
CLIP-seq Support 1 for dataset GSM545213 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000425103.1 | 3UTR | CACUACAGUGACGAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
60 hsa-miR-190b Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT054581 | IGF1 | insulin like growth factor 1 | ![]() |
![]() |
![]() |
![]() |
4 | 1 | ||||
MIRT066966 | ATXN7L3B | ataxin 7 like 3B | ![]() |
![]() |
2 | 2 | ||||||
MIRT192449 | SPRED1 | sprouty related EVH1 domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT250414 | TNRC6A | trinucleotide repeat containing 6A | ![]() |
![]() |
2 | 2 | ||||||
MIRT306294 | KLHL24 | kelch like family member 24 | ![]() |
![]() |
2 | 2 | ||||||
MIRT355845 | SGMS2 | sphingomyelin synthase 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT437770 | MTMR6 | myotubularin related protein 6 | ![]() |
1 | 1 | |||||||
MIRT437771 | MTMR6 | myotubularin related protein 6 | ![]() |
1 | 1 | |||||||
MIRT437772 | Mtmr6 | myotubularin related protein 6 | ![]() |
1 | 1 | |||||||
MIRT444672 | CDKL2 | cyclin dependent kinase like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT446389 | PCDHB11 | protocadherin beta 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT446634 | SDC3 | syndecan 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT449410 | TRIM5 | tripartite motif containing 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT449560 | GPC5 | glypican 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT469928 | PTPRJ | protein tyrosine phosphatase, receptor type J | ![]() |
![]() |
2 | 6 | ||||||
MIRT473736 | MAP3K9 | mitogen-activated protein kinase kinase kinase 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT474210 | LDHA | lactate dehydrogenase A | ![]() |
![]() |
2 | 2 | ||||||
MIRT474583 | KLF6 | Kruppel like factor 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT476732 | FOXN2 | forkhead box N2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT478455 | DAB2 | DAB2, clathrin adaptor protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT495327 | ADAMTS8 | ADAM metallopeptidase with thrombospondin type 1 motif 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT498615 | MTRNR2L10 | MT-RNR2-like 10 | ![]() |
![]() |
2 | 12 | ||||||
MIRT501734 | OVOL1 | ovo like transcriptional repressor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT501849 | MTRNR2L8 | MT-RNR2-like 8 | ![]() |
![]() |
2 | 14 | ||||||
MIRT504678 | CYGB | cytoglobin | ![]() |
![]() |
2 | 4 | ||||||
MIRT506517 | MSANTD4 | Myb/SANT DNA binding domain containing 4 with coiled-coils | ![]() |
![]() |
2 | 6 | ||||||
MIRT507984 | BCL2L13 | BCL2 like 13 | ![]() |
![]() |
2 | 4 | ||||||
MIRT508444 | ZNF608 | zinc finger protein 608 | ![]() |
![]() |
2 | 4 | ||||||
MIRT511366 | IL6ST | interleukin 6 signal transducer | ![]() |
![]() |
2 | 4 | ||||||
MIRT520515 | TRA2B | transformer 2 beta homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT524571 | CALML4 | calmodulin like 4 | ![]() |
![]() |
2 | 4 | ||||||
MIRT531896 | INVS | inversin | ![]() |
![]() |
2 | 4 | ||||||
MIRT533916 | TATDN2 | TatD DNase domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT537503 | FAM13B | family with sequence similarity 13 member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT541689 | CCDC160 | coiled-coil domain containing 160 | ![]() |
![]() |
2 | 8 | ||||||
MIRT544419 | ZNF460 | zinc finger protein 460 | ![]() |
![]() |
2 | 4 | ||||||
MIRT544615 | CSDE1 | cold shock domain containing E1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT545076 | IL7R | interleukin 7 receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT545849 | ZNF264 | zinc finger protein 264 | ![]() |
![]() |
2 | 4 | ||||||
MIRT547436 | MED4 | mediator complex subunit 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT550157 | ZNF223 | zinc finger protein 223 | ![]() |
![]() |
2 | 4 | ||||||
MIRT553948 | STAMBP | STAM binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT554395 | SERP1 | stress associated endoplasmic reticulum protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT555667 | PGAM4 | phosphoglycerate mutase family member 4 | ![]() |
![]() |
2 | 4 | ||||||
MIRT564193 | PM20D2 | peptidase M20 domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT566792 | MKL2 | MKL1/myocardin like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT566843 | LRRC58 | leucine rich repeat containing 58 | ![]() |
![]() |
2 | 2 | ||||||
MIRT572516 | KIAA0232 | KIAA0232 | ![]() |
![]() |
2 | 2 | ||||||
MIRT607428 | NOTCH2NL | notch 2 N-terminal like | ![]() |
![]() |
2 | 10 | ||||||
MIRT627779 | RAB30 | RAB30, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT635159 | ENO4 | enolase family member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT642159 | ADCYAP1R1 | ADCYAP receptor type I | ![]() |
![]() |
![]() |
3 | 2 | |||||
MIRT646205 | DUSP10 | dual specificity phosphatase 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT657007 | KCNMB4 | potassium calcium-activated channel subfamily M regulatory beta subunit 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT665817 | TMEM161B | transmembrane protein 161B | ![]() |
![]() |
2 | 2 | ||||||
MIRT667488 | MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT707098 | ZNF850 | zinc finger protein 850 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708719 | PTPLAD2 | 3-hydroxyacyl-CoA dehydratase 4 | ![]() |
1 | 1 | |||||||
MIRT735521 | HUS1 | HUS1 checkpoint clamp component | ![]() |
![]() |
![]() |
3 | 0 | |||||
MIRT736644 | AGPAT3 | 1-acylglycerol-3-phosphate O-acyltransferase 3 | ![]() |
![]() |
2 | 0 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|